- Business Wire•3 days agoThe Medicines Company Announces FDA Filing Acceptance of New Drug Application for Intravenous Antibiotic Carbavance® (meropenem-vaborbactam)
The Medicines Company today announced that the U.S. Food and Drug Administration has accepted for priority review the Company’s new drug application filing for Carbavance® for the treatment of complicated urinary tract infections .
- Business Wire•7 days agoThe Medicines Company to Announce Fourth-Quarter and Full-Year 2016 Financial Results on February 28, 2017
The Medicines Company will host a conference call on Tuesday, February 28, 2017, at 8:30 a.m., Eastern Time, to discuss fourth-quarter and full-year 2016 financial results and operational developments.
- TheStreet.com•9 days ago
Ardelyx, Acorda Therapeutics and Medicines Co. were among the premarket biotech movers on Wednesday.
MDCO : Summary for The Medicines Company - Yahoo Finance
The Medicines Company (MDCO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||40.00 x 300|
|Day's Range||51.49 - 52.58|
|52 Week Range||29.48 - 54.01|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-17.81|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|